November 12, 2018
Last week, Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics released their third quarter financial results.
All three of the biotech companies are currently developing treatments using CRISPR-Cas9 gene editing technology. They are also all still pre...
November 6, 2018
One area of the biotech industry I find particularly interesting is genetic engineering.
For the past few months, I've been closely following the race between three similar publicly traded companies, all of which are competing to get the first genome editing t...
Some General Thoughts on Investing and Retirement
February 1, 2019
Rewriting the Code of Life with CRISPR-Cas9
The Ethics of Coding Living Things
Foreign exchange market
Foreign exchange trading